Document Detail

Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients.
MedLine Citation:
PMID:  6173518     Owner:  NLM     Status:  MEDLINE    
The antihypertensive effect of a slow-release (SR) clonidine preparation was evaluated in hypertensive patients not confined to bed using a 24-h intraarterial blood pressure monitoring (Oxford) method. The monitoring was carried out during placebo administration and after 7-10 days of daily administration of SR clonidine in a single oral dose (250 or 500 microgram). An analysis of all the blood pressure values obtained was performed by computer. The results were as follows: (a) SR clonidine significantly reduced the 24-h systolic and diastolic arterial pressure by 16 and 10 mm Hg, respectively (mean +/- SE). (b) The reduction was well evident throughout the 24-h period, the average decrease in mean arterial pressure observed during the first, second, and third 8-h period after the administration of the drug being 11, 14, and 14 mm Hg, respectively. (c) The blood pressure reduction was similar during the daytime and the nighttime, despite the lower base-line value that occurred in the latter condition. (d) There was no consistent change in blood pressure variability, as measured in each patient by the standard deviation of the blood pressure values, with SR clonidine. SR clonidine caused a reduction in heart rate that, as that in blood pressure, was well evident throughout the 24 h. It is concluded that SR clonidine is an effective antihypertensive agent and that a single administration of this drug can produce a clear-cut reduction in the blood pressure values of hypertensive patients for a 24-h period.
G Mancia; A Ferrari; L Gregorini; G Parati; G Pomidossi; G Grassi; G Bertinieri; A Zanchetti
Related Documents :
9203168 - Cardiovascular parameters of heroin-withdrawn addicts treated with guanfacine.
2455198 - Role of the central nervous system in human secondary hypertension.
2998158 - Cerebrovascular responses to haemorrhagic hypotension in anaesthetized cats. effects of...
3011828 - Effects of clonidine on cerebral blood flow and the response to arterial co2.
3475728 - Mechanism of complement-mediated thromboxane production by the perfused rabbit liver: l...
214268 - Haemodynamics of orally-active converting enzyme inhibitor (sq 14225) in hypertensive p...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  3     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1981 Nov-Dec
Date Detail:
Created Date:  1982-04-22     Completed Date:  1982-04-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1193-202     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects*
Clonidine / administration & dosage*,  pharmacology
Delayed-Action Preparations
Heart Rate / drug effects
Hypertension / drug therapy*
Middle Aged
Reg. No./Substance:
0/Delayed-Action Preparations; 4205-90-7/Clonidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of 2-phenylaminoadenosine (CV-1808) on ischemic ST-segment elevation in anesthetized dogs.
Next Document:  Vagus-induced changes in ventricular electrophysiology of the dog heart with and without beta-blocka...